Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ANTIRETROVIRAL TREATMENT”

1,553 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,553 results

Not applicableStudy completedNCT01957917
What this trial is testing

Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Who this might be right for
HIV
University of California, Berkeley 800
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Large-scale testing (Phase 3)UnknownNCT00199979
What this trial is testing

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Who this might be right for
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
MEDEX 250
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Not applicableUnknownNCT03878186
What this trial is testing

Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral

Who this might be right for
HIVThreat Appraisal
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 50
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Large-scale testing (Phase 3)Study completedNCT00301561
What this trial is testing

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Who this might be right for
HIV InfectionsAIDS
French National Agency for Research on AIDS and Viral Hepatitis 459
Not applicableStudy completedNCT00661960
What this trial is testing

Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy

Who this might be right for
HIV InfectionsAIDS
University of California, Davis 25
Not applicableStudy completedNCT02384395
What this trial is testing

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection

Who this might be right for
HIVAcute HIV Infection
University of North Carolina, Chapel Hill 40
Early research (Phase 1)Study completedNCT00006509
What this trial is testing

The Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Study completedNCT02208167
What this trial is testing

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

Who this might be right for
HIV
University of North Carolina, Chapel Hill 6
Not applicableEnded earlyNCT02818283
What this trial is testing

Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention

Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionHypercholesterolemia
Ohio State University 1
Not applicableStudy completedNCT01061957
What this trial is testing

Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

Who this might be right for
HIV Infections
Rigshospitalet, Denmark 96
Not applicableUnknownNCT05687565
What this trial is testing

Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV

Who this might be right for
HIV Infections
Hospital Universitari Vall d'Hebron Research Institute 27
Early research (Phase 1)Study completedNCT00129194
What this trial is testing

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Who this might be right for
HIV Infections
Koronis Pharmaceuticals. 40
Not applicableLooking for participantsNCT00825929
What this trial is testing

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Who this might be right for
HIV Infections
Radboud University Medical Center 176
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Testing effectiveness (Phase 2)Looking for participantsNCT07336797
What this trial is testing

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Who this might be right for
Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud 66
Not applicableStudy completedNCT02060162
What this trial is testing

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Who this might be right for
Hepatitis B VirusHIVAntiretroviral Therapy+3 more
University of Alabama at Birmingham 897
Not applicableStudy completedNCT01869010
What this trial is testing

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

Who this might be right for
HIV Infection
Hospital Italiano de Buenos Aires 30
Next Page